October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 European Society of Cardiology (ESC) Congress.
Drones Could Deliver Defibrillators to Cardiac Arrest Victims Faster Than Ambulances
CT Coronary Perivascular Fat Assessment Can Stratify Cardiac Risk Associated With High-Risk Plaques
Systematic FFR Assessment Did Not Add Benefit During Diagnostic Angiography
Carotid Surgery Versus Stenting Have Similar Long-term Effects on Stroke
Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman
One-month Clopidogrel Monotherapy After PCI Not Supported in STOPDAPT-2 ACS Trial
Edoxaban May Be Effective Treatment for Atrial Fibrillation After TAVR
GUIDE-HF Trial Shows Hemodynamic Guided Management Benefits Larger Heart Failure Population
Implantable Cardiac Monitors Predict Complications in Selected Post-myocardial Infarction Patients
Continuous Heart Rhythm Monitoring and Anticoagulation Does Not Prevent Stroke
TOMAHAWK Trial Does Not Support Early Coronary Angiography in Cardiac Arrest Without ST-elevation
Fibrosis Ablation Shows Promise in AFib With Low Grade Fibrotic Myopathy
MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients
Empagliflozin Benefits Heart Failure Patients With Reduced and Preserved Ejection Fraction
One in 10 Cardiac Arrest Patients Phoned Emergency Services the Day Before
PRONOUNCE Trial Does not Resolve if Androgen Deprivation Therapy Causes Cardiac Safety Issues
Other News From During ESC 2021:
ESC Releases Guidelines on Heart Failure Management
New European Guidelines on Valvular Heart Disease Published
ESC Issues Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
August 29, 2025 
